2022-10-26 | Sale | Vaxcyte, Inc. PCVX | VP, Research | 10,000 0.0151% | $40.00 | $400,000 | +14.17% | |
2022-10-11 | Sale | Vaxcyte, Inc. PCVX | VP, Research | 5,000 0.0079% | $25.50 | $127,500 | +84.91% | |
2022-09-02 | Sale | Vaxcyte, Inc. PCVX | VP, Research | 336 0.0006% | $27.14 | $9,118 | +70.24% | |
2022-08-04 | Sale | Vaxcyte, Inc. PCVX | VP, Research | 5,000 0.0081% | $25.70 | $128,508 | +71.9% | |
2022-05-20 | Sale | Vaxcyte, Inc. PCVX | VP, Research | 4,112 0.0066% | $25.50 | $104,856 | +44.28% | |
2022-05-05 | Sale | Vaxcyte, Inc. PCVX | VP, Research | 888 0.0015% | $25.80 | $22,914 | +48.66% | |
2022-04-05 | Sale | Vaxcyte, Inc. PCVX | VP, Research | 5,000 0.0082% | $25.59 | $127,950 | +3.5% | |
2022-03-11 | Sale | Vaxcyte, Inc. PCVX | VP, Research | 10,000 0.0182% | $25.50 | $255,000 | +7.18% | |
2021-12-27 | Sale | Vaxcyte, Inc. PCVX | VP, Research | 9,500 0.0187% | $23.60 | $224,185 | +6.93% | |
2021-12-16 | Sale | Vaxcyte, Inc. PCVX | VP, Research | 9,238 0.0189% | $22.50 | $207,855 | +15.6% | |
2021-12-09 | Sale | Vaxcyte, Inc. PCVX | VP, Research | 262 0.0005% | $22.50 | $5,895 | +14.07% | |
2021-10-26 | Sale | Vaxcyte, Inc. PCVX | VP, Research | 9,500 0.0183% | $22.69 | $215,555 | +5.96% | |
2021-09-27 | Sale | Vaxcyte, Inc. PCVX | VP, Research | 9,500 0.0182% | $26.17 | $248,606 | -8.38% | |
2021-08-26 | Sale | Vaxcyte, Inc. PCVX | VP, Research | 9,500 0.0185% | $25.38 | $241,086 | -4.06% | |
2021-07-26 | Sale | Vaxcyte, Inc. PCVX | VP, Research | 9,500 0.0099% | $12.24 | $116,328 | +5.3% | |
2021-06-28 | Sale | Vaxcyte, Inc. PCVX | VP, Research | 9,500 0.0187% | $24.37 | $231,540 | -2.13% | |
2021-06-07 | Sale | Vaxcyte, Inc. PCVX | VP, Research | 19,000 0.0361% | $22.50 | $427,500 | +2.48% | |
2021-03-26 | Sale | Vaxcyte, Inc. PCVX | VP, Research | 9,500 0.0187% | $23.88 | $226,866 | -4.88% | |
2021-02-26 | Sale | Vaxcyte, Inc. PCVX | VP, Research | 9,500 0.0189% | $23.93 | $227,326 | -4.12% | |
2021-01-26 | Sale | Vaxcyte, Inc. PCVX | VP, Research | 9,500 0.019% | $25.27 | $240,029 | -6.59% |